Abstract
Nitrous oxide (N2O) has recently emerged as a potential fast-acting antidepressant but the cerebral mechanisms involved in this effect remain speculative. We hypothesized that the antidepressant response to an Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) would be associated with changes in cerebral connectivity and brain tissue pulsations (BTP). Thirty participants (20 with a major depressive episode resistant to at least one antidepressant and 10 healthy controls—HC, aged 25–50, only females) were exposed to a 1-h single session of EMONO and followed for 1 week. We defined response as a reduction of at least 50% in the MADRS score 1 week after exposure. Cerebral connectivity of the Anterior Cingulate Cortex (ACC), using ROI-based resting state fMRI, and BTP, using ultrasound Tissue Pulsatility Imaging, were compared before and rapidly after exposure (as well as during exposure for BTP) among HC, non-responders and responders. We conducted analyses to compare group × time, group, and time effects. Nine (45%) depressed participants were considered responders and eleven (55%) non-responders. In responders, we observed a significant reduction in the connectivity of the subgenual ACC with the precuneus. Connectivity of the supracallosal ACC with the mid-cingulate also significantly decreased after exposure in HC and in non-responders. BTP significantly increased in the three groups between baseline and gas exposure, but the increase in BTP within the first 10 min was only significant in responders. We found that a single session of EMONO can rapidly modify the functional connectivity in the subgenual ACC-precuneus, nodes within the default mode network, in depressed participants responders to EMONO. In addition, larger increases in BTP, associated with a significant rise in cerebral blood flow, appear to promote the antidepressant response, possibly by facilitating optimal drug delivery to the brain. Our study identified potential cerebral mechanisms related to the antidepressant response of N2O, as well as potential markers for treatment response with this fast-acting antidepressant.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41380-023-02217-6/MediaObjects/41380_2023_2217_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41380-023-02217-6/MediaObjects/41380_2023_2217_Fig2_HTML.png)
Similar content being viewed by others
References
Guimarães MC, Guimarães TM, Hallak JE, Abrão J, Machado-de-Sousa JP. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial. Braz J Psychiatry. 2021;43:484–93.
Liu H, Kerzner J, Demchenko I, Wijeysundera DN, Kennedy SH, Ladha KS, et al. Nitrous oxide for the treatment of psychiatric disorders: a systematic review of the clinical trial landscape. Acta Psychiatr Scand. 2022;146:126–38.
Nagele P, Palanca BJ, Gott B, Brown F, Barnes L, Nguyen T, et al. A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Sci Transl Med. 2021;13;eabe1376.
Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, et al. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol Psychiatry. 2015;78:10–18.
Yan D, Liu B, Wei X, Ou W, Liao M, Ji S, et al. Efficacy and safety of nitrous oxide for patients with treatment-resistant depression, a randomized controlled trial. Psychiatry Res. 2022;317:114867.
Quach DF, de Leon VC, Conway CR. Nitrous Oxide: an emerging novel treatment for treatment-resistant depression. J Neurol Sci. 2022;434:120092.
Izumi Y, Hsu F-F, Conway CR, Nagele P, Mennerick SJ, Zorumski CF. Nitrous oxide, a rapid antidepressant, has ketamine-like effects on excitatory transmission in the adult hippocampus. Biol Psychiatry. 2022;92:964–72.
Chamaa F, Bahmad HF, Makkawi A-K, Chalhoub RM, Al-Chaer ED, Bikhazi GB, et al. Nitrous oxide induces prominent cell proliferation in adult rat hippocampal dentate gyrus. Front Cell Neurosci. 2018;12:135.
Kim WSH, Dimick MK, Omrin D, Mitchell RHB, Riegert D, Levitt A, et al. Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement. Bipolar Disord. 2023;25:221–32.
Gerlach AR, Karim HT, Peciña M, Ajilore O, Taylor WD, Butters MA, et al. MRI predictors of pharmacotherapy response in major depressive disorder. Neuroimage Clin. 2022;36:103157.
Alexander L, Jelen LA, Mehta MA, Young AH. The anterior cingulate cortex as a key locus of ketamine’s antidepressant action. Neurosci Biobehav Rev. 2021;127:531–54.
Kucewicz JC, Dunmire B, Leotta DF, Panagiotides H, Paun M, Beach KW. Functional tissue pulsatility imaging of the brain during visual stimulation. Ultrasound Med Biol. 2007;33:681–90.
Kucewicz JC, Dunmire B, Giardino ND, Leotta DF, Paun M, Dager SR, et al. Tissue pulsatility imaging of cerebral vasoreactivity during hyperventilation. Ultrasound Med Biol. 2008;34:1200–8.
Biogeau J, Desmidt T, Dujardin P, Ternifi R, Eudo C, Vierron E, et al. Ultrasound tissue pulsatility imaging suggests impairment in global brain pulsatility and small vessels in elderly patients with orthostatic hypotension. J Stroke Cerebrovasc Dis. 2017;26:246–51.
Siragusa MA, Brizard B, Dujardin P-A, Réméniéras J-P, Patat F, Gissot V, et al. When classical music relaxes the brain: an experimental study using ultrasound brain tissue pulsatility imaging. Int J Psychophysiol. 2020;150:29–36.
Desmidt T, Andersson F, Brizard B, Cottier J-P, Patat F, Gissot V, et al. Cerebral blood flow velocity positively correlates with brain volumes in long-term remitted depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:243–9.
Baranauskas M, Jurkonis R, Lukoševičius A, Makūnaitė M, Matijošaitis V, Gleiznienė R, et al. Ultrasonic assessment of the medial temporal lobe tissue displacements in Alzheimer’s disease. Diagnostics 2020;10:452.
Ternifi R, Cazals X, Desmidt T, Andersson F, Camus V, Cottier J-P, et al. Ultrasound measurements of brain tissue pulsatility correlate with the volume of MRI white-matter hyperintensity. J Cereb Blood Flow Metab. 2014;34:942–4.
Ince J, Banahan C, Venturini S, Alharbi M, Turner P, Oura M, et al. Acute ischemic stroke diagnosis using brain tissue pulsations. J Neurol Sci. 2020;419:117164.
Palta P, Sharrett AR, Wei J, Meyer ML, Kucharska‐Newton A, Power MC, et al. Central arterial stiffness is associated with structural brain damage and poorer cognitive performance: the ARIC study. J Am Heart Assoc. 2019;8:e011045.
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, et al. Neuroinflammation and depression: a review. Eur J Neurosci. 2021;53:151–71.
Desmidt T, Dujardin P-A, Brizard B, Réméniéras J-P, Gissot V, Dufour-Rainfray D, et al. Decrease in ultrasound brain tissue pulsations as a potential surrogate marker of response to antidepressant. J Psychiatr Res. 2022;146:186–91.
Desmidt T, Brizard B, Dujardin P-A, Ternifi R, Réméniéras J-P, Patat F, et al. Brain tissue pulsatility is increased in mid-life depression: a comparative study using ultrasound tissue pulsatility imaging. Neuropsychopharmacology. 2017;42:2575–82.
Desmidt T, Gissot V, Dujardin P-A, Andersson F, Barantin L, Brizard B, et al. A case of sustained antidepressant effects and large changes in the brain with a single brief exposure to nitrous oxide. Am J Geriatr Psychiatry. 2021;29:1298–1300.
Rolls ET, Huang C-C, Lin C-P, Feng J, Joliot M. Automated anatomical labelling atlas 3. NeuroImage. 2020;206:116189.
Gerlach AR, Karim HT, Peciña M, Ajilore O, Taylor WD, Butters MA, et al. MRI predictors of pharmacotherapy response in major depressive disorder. NeuroImage Clin. 2022;36:103157.
Dashdorj N, Corrie K, Napolitano A, Petersen E, Mahajan RP, Auer DP. Effects of subanesthetic dose of nitrous oxide on cerebral blood flow and metabolism: a multimodal magnetic resonance imaging study in healthy volunteers. Anesthesiology. 2013;118:577–86.
Parkes LM, Rashid W, Chard DT, Tofts PS. Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med. 2004;51:736–43.
de Lacy N, McCauley E, Kutz JN, Calhoun VD. Sex-related differences in intrinsic brain dynamism and their neurocognitive correlates. NeuroImage. 2019;202:116116.
Karim HT, Andreescu C, Tudorascu D, Smagula SF, Butters MA, Karp JF, et al. Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters. Mol Psychiatry. 2017;22:450–7.
Buhre W, Disma N, Hendrickx J, DeHert S, Hollmann MW, Huhn R, et al. European society of anaesthesiology task force on nitrous oxide: a narrative review of its role in clinical practice. Br J Anaesth. 2019;122:587–604.
Johnson KM, Devine JM, Ho KF, Howard KA, Saretsky TL, Jamieson CA. Evidence to support montgomery-asberg depression rating scale administration every 24 h to assess rapid onset of treatment response. J Clin Psychiatry. 2016;77:21987.
Penny WD, Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE. Statistical parametric map**: the analysis of functional brain images. Amsterdam: Elsevier; 2011.
Patel AX, Kundu P, Rubinov M, Jones PS, Vértes PE, Ersche KD, et al. A wavelet method for modeling and despiking motion artifacts from resting-state fMRI time series. Neuroimage. 2014;95:287–304.
Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage. 2007;37:90–101.
Lindquist MA, Geuter S, Wager TD, Caffo BS. Modular preprocessing pipelines can reintroduce artifacts into fMRI data. Hum Brain Mapp. 2019;40:2358–76.
Evans DH. Colour flow and motion imaging. Proc Mechanical Engineers, Part H: J Eng Med. 2010;224:241–53.
Yiu BYS, Lai SSM, Yu ACH. Vector projectile imaging: time-resolved dynamic visualization of complex flow patterns. Ultrasound Med Biol. 2014;40:2295–309.
Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Human brain map**. 2002;15:1–25.
Hamilton JP, Farmer M, Fogelman P, Gotlib IH. Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biol Psychiatry. 2015;78:224–30.
Demchenko I, Tassone VK, Kennedy SH, Dunlop K, Bhat V. Intrinsic connectivity networks of glutamate-mediated antidepressant response: a neuroimaging review. Front Psychiatry. 2022;13:864902.
Dandekar MP, Fenoy AJ, Carvalho AF, Soares JC, Quevedo J. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications. Mol Psychiatry. 2018;23:1094–112.
Philip NS, Barredo J, Aiken E, Carpenter LL. Neuroimaging mechanisms of therapeutic transcranial magnetic stimulation for major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:211–22.
Lin Y, Pan Y, Wang M, Huang X, Yin Y, Wang Y, et al. Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat. Lab Invest. 2012;92:1623–34.
Zhang X, Zhu HC, Yang D, Zhang FC, Mane R, Sun SJ, et al. Association between cerebral blood flow changes and blood-brain barrier compromise in spontaneous intracerebral haemorrhage. Clin Radio. 2022;77:833–9.
Lieberman MD, Eisenberger NI. The dorsal anterior cingulate cortex is selective for pain: results from large-scale reverse inference. Proc Natl Acad Sci USA. 2015;112:15250–5.
Bliss TVP, Collingridge GL, Kaang B-K, Zhuo M. Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain. Nat Rev Neurosci. 2016;17:485–96.
Bloch Y, Belmaker RH, Shvartzman P, Romem P, Bolotin A, Bersudsky Y, et al. Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial. Sci Rep. 2021;11:18911.
Acknowledgements
The PROTOBRAIN study was supported by grants from “La Fondation de l’Avenir pour la Recherche Médicale (grant no. DLAM_2017251)” and from “La Fondation Planiol pour la Recherche sur le Cerveau.”
Author information
Authors and Affiliations
Contributions
TD designed the study, enrolled the depressed participants and wrote the manuscript. PAD performed the ultrasound recording and signal processing and wrote the manuscript. FA performed the MRI pre-processing and wrote the manuscript. BB performed the ultrasound recording. JPR designed the ultrasound signal processing and wrote the manuscript. VG enrolled the healthy volunteers and supervised the gas exposure. NA supervised the provision of the gas. LB supervised the MRI acquisitions. FE advised for the gas exposure. PP performed the statistics. HTK performed the MRI pre- and post-processing, analyzed the MRI data and wrote the manuscript. All authors critically reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
TD reports personal fees from Janssen and Lundbeck. WEH reports personal fees from Air Liquide, Eisai, Janssen, Lundbeck, Otsuka, UCB and Chugai. VC reports personal fees from Janssen, Bristol Myers Squibb and AA Pharma. All other authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Desmidt, T., Dujardin, PA., Andersson, F. et al. Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study. Mol Psychiatry 28, 3900–3908 (2023). https://doi.org/10.1038/s41380-023-02217-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-023-02217-6
- Springer Nature Limited